Showing results (101-110 of 146) with videos related to
Sort By:
Pageof 15
World Journal of Surgery|August 1, 2008
Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experienceMarco Niedergethmann, Robert Grützmann, Ralf Hildenbrand, et al.World Journal of Surgical Oncology|August 4, 2018
Impact of adjuvant chemotherapy on patients with ypT0-2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospitalChristian Galata, Kirsten Merx, Sabine Mai, et al.Digestion|September 29, 2017
Prevalence and Incidence of Autoimmune Pancreatitis in the Population Living in the Southwest of GermanyAlexander Schneider, Henrik Michaely, Christel Weiss, et al.Journal of Neurogastroenterology and Motility|January 16, 2019
Success and Complication Rates After Sacral Neuromodulation for Fecal Incontinence and Constipation: A Single-center Follow-up StudyBernhard Widmann, Christian Galata, Rene Warschkow, et al.Digestion|December 14, 2002
Vasoactive intestinal polypeptide and gastrin-releasing peptide attenuate hepatic microvasculatory disturbances following intestinal ischemia and reperfusionIngo Leister, Ebenzar M Mbachu, Stefan Post, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancersDenis Martin Schewe, Tobias Biller, Gabriele Maurer, et al.Oncology Reports|September 14, 2006
Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancerWilko I Staiger, Johannes F Coy, Rainer Grobholz, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 31, 2013
Malignancy in chronic pancreatitis: analysis of diagnostic procedures and proposal of a clinical algorithmFelix Rückert, Torsten Brussig, Matthias Kuhn, et al.Cancer|July 2, 2009
Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancerDaniel Buergy, Tina Fuchs, Patryk Kambakamba, et al.International Journal of Cancer|May 30, 2009
Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignanciesDaniel Buergy, Theresia Weber, Gabriele D Maurer, et al.Pageof 15